Osypka AG Partners with Armira to Expand Medical Innovations
Deal News | Apr 28, 2025 | William Blair Capital Partners

Armira, an investment holding company based in Munich, has entered a partnership with Osypka AG, a leading provider in medical technology. This partnership signifies Armira's strategic focus on direct equity investments in medium-sized, profitable family businesses across the DACH region and beyond. Osypka AG, known for its innovative approaches in interventional and pediatric cardiology as well as cardiac surgery, aims to leverage this partnership to further develop its advanced products globally, especially in the field of electrically active implants and neurostimulation. Founded by Prof. Dr. Peter Osypka, Osypka AG has been at the frontier of technical excellence since 1977, enhancing patient care and life quality worldwide. This collaboration reflects Armira's long-term investment perspective backed by wealthy entrepreneurs and families, with an emphasis on resilience and growth.
Sectors
- Private Equity
- Medical Technology
Geography
- Germany – Armira is based in Munich, Germany, and the partnership involves expanding operations in the DACH region.
- Global – Osypka AG provides advanced medical technology solutions globally, indicating its international presence and market reach.
Industry
- Private Equity – Armira is an investment holding company focused on direct equity investments, indicative of its role in the Private Equity industry.
- Medical Technology – Osypka AG is a provider of innovative medical technology solutions, focusing on interventional and pediatric cardiology and cardiac surgery.
Financials
Participants
Name | Role | Type | Description |
---|---|---|---|
Armira | Investment Partner | Company | A Munich-based investment holding company focusing on equity investments in medium-sized and family businesses. |
Osypka AG | Target Company | Company | An innovative provider in medical technology, known for cardiology and cardiac surgery solutions. |